phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

High BMI eligibility for semaglutide could cost Medicare an additional $145 billion annually

A brief research report found that 61% of Medicare-eligible adults have a BMI of 27 or higher, which means they may benefit from a GLP-1 receptor agonist like semaglutide for weight loss.

August 26, 2024


March 17 2026

March 16 2026

March 15 2026

March 14 2026

March 13 2026

March 12 2026

March 11 2026

March 10 2026

March 9 2026

March 8 2026

March 7 2026

March 6 2026

March 5 2026

March 4 2026

March 3 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy